BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 34236445)

  • 21. Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis.
    Mäkitie RE; Hackl M; Weigl M; Frischer A; Kämpe A; Costantini A; Grillari J; Mäkitie O
    J Bone Miner Res; 2020 Oct; 35(10):1962-1973. PubMed ID: 32453450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skeletal Characteristics of WNT1 Osteoporosis in Children and Young Adults.
    Mäkitie RE; Haanpää M; Valta H; Pekkinen M; Laine CM; Lehesjoki AE; Schalin-Jäntti C; Mäkitie O
    J Bone Miner Res; 2016 Sep; 31(9):1734-42. PubMed ID: 27005318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. More severe phenotype of early-onset osteoporosis associated with recessive form of LRP5 and combination with DKK1 or WNT3A.
    Caetano da Silva C; Ricquebourg M; Orcel P; Fabre S; Funck-Brentano T; Cohen-Solal M; Collet C
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1681. PubMed ID: 33939331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic yield of bone fragility gene panel sequencing in children and young adults referred for idiopathic primary osteoporosis at a single regional reference centre.
    Rouleau C; Malorie M; Collet C; Porquet-Bordes V; Gennero I; Eddiry S; Laroche M; Salles JP; Couture G; Edouard T
    Bone Rep; 2022 Jun; 16():101176. PubMed ID: 35252483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis in children and young adults.
    Sakka SD
    Best Pract Res Clin Rheumatol; 2022 Sep; 36(3):101776. PubMed ID: 36109301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.
    Mäkitie RE; Kämpe A; Costantini A; Alm JJ; Magnusson P; Mäkitie O
    J Bone Miner Res; 2020 May; 35(5):901-912. PubMed ID: 31968132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics.
    Fahiminiya S; Majewski J; Al-Jallad H; Moffatt P; Mort J; Glorieux FH; Roschger P; Klaushofer K; Rauch F
    J Bone Miner Res; 2014 Aug; 29(8):1805-14. PubMed ID: 24616189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic variability in patients with osteogenesis imperfecta caused by BMP1 mutations.
    Pollitt RC; Saraff V; Dalton A; Webb EA; Shaw NJ; Sobey GJ; Mughal MZ; Hobson E; Ali F; Bishop NJ; Arundel P; Högler W; Balasubramanian M
    Am J Med Genet A; 2016 Dec; 170(12):3150-3156. PubMed ID: 27576954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe osteoporosis with multiple spontaneous vertebral fractures in a young male carrying triple polymorphisms in the vitamin D receptor, collagen type 1, and low-density lipoprotein receptor-related peptide 5 genes.
    Yavropoulou MP; Kollia P; Chatzidimitriou D; Samara S; Skoura L; Yovos JG
    Hormones (Athens); 2016 Oct; 15(4):551-556. PubMed ID: 28222408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.
    Lv F; Ma M; Liu W; Xu X; Song Y; Li L; Jiang Y; Wang O; Xia W; Xing X; Qiu Z; Li M
    Osteoporos Int; 2017 Sep; 28(9):2691-2700. PubMed ID: 28620780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Discoveries in Monogenic Disorders of Childhood Bone Fragility.
    Mäkitie RE; Kämpe AJ; Taylan F; Mäkitie O
    Curr Osteoporos Rep; 2017 Aug; 15(4):303-310. PubMed ID: 28646443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.
    Kämpe AJ; Costantini A; Levy-Shraga Y; Zeitlin L; Roschger P; Taylan F; Lindstrand A; Paschalis EP; Gamsjaeger S; Raas-Rothschild A; Hövel M; Jiao H; Klaushofer K; Grasemann C; Mäkitie O
    J Bone Miner Res; 2017 Dec; 32(12):2394-2404. PubMed ID: 28777485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2.
    Pekkinen M; Terhal PA; Botto LD; Henning P; Mäkitie RE; Roschger P; Jain A; Kol M; Kjellberg MA; Paschalis EP; van Gassen K; Murray M; Bayrak-Toydemir P; Magnusson MK; Jans J; Kausar M; Carey JC; Somerharju P; Lerner UH; Olkkonen VM; Klaushofer K; Holthuis JC; Mäkitie O
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis.
    Peris P; Monegal A; Mäkitie RE; Guañabens N; González-Roca E
    Osteoporos Int; 2023 Feb; 34(2):405-411. PubMed ID: 36396825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
    Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M
    BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome.
    Caffarelli C; Gonnelli S; Pitinca MDT; Camarri S; Al Refaie A; Hayek J; Nuti R
    BMC Med Genet; 2020 Jan; 21(1):21. PubMed ID: 32005172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Part I: Which Child with a Chronic Disease Needs Bone Health Monitoring?
    Ward LM
    Curr Osteoporos Rep; 2021 Jun; 19(3):278-288. PubMed ID: 34245406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations That Alter the Carboxy-Terminal-Propeptide Cleavage Site of the Chains of Type I Procollagen Are Associated With a Unique Osteogenesis Imperfecta Phenotype.
    Cundy T; Dray M; Delahunt J; Hald JD; Langdahl B; Li C; Szybowska M; Mohammed S; Duncan EL; McInerney-Leo AM; Wheeler PG; Roschger P; Klaushofer K; Rai J; Weis M; Eyre D; Schwarze U; Byers PH
    J Bone Miner Res; 2018 Jul; 33(7):1260-1271. PubMed ID: 29669177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PLS3 mutations in X-linked osteoporosis with fractures.
    van Dijk FS; Zillikens MC; Micha D; Riessland M; Marcelis CL; de Die-Smulders CE; Milbradt J; Franken AA; Harsevoort AJ; Lichtenbelt KD; Pruijs HE; Rubio-Gozalbo ME; Zwertbroek R; Moutaouakil Y; Egthuijsen J; Hammerschmidt M; Bijman R; Semeins CM; Bakker AD; Everts V; Klein-Nulend J; Campos-Obando N; Hofman A; te Meerman GJ; Verkerk AJ; Uitterlinden AG; Maugeri A; Sistermans EA; Waisfisz Q; Meijers-Heijboer H; Wirth B; Simon ME; Pals G
    N Engl J Med; 2013 Oct; 369(16):1529-36. PubMed ID: 24088043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations.
    Joeng KS; Lee YC; Jiang MM; Bertin TK; Chen Y; Abraham AM; Ding H; Bi X; Ambrose CG; Lee BH
    Hum Mol Genet; 2014 Aug; 23(15):4035-42. PubMed ID: 24634143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.